Global Telmisartan Market Research Report 2020

Publisher Name :
Date: 17-Mar-2020
No. of pages: 121
Inquire Before Buying

The global Telmisartan market is valued at US$ 3320.7 million in 2020 is expected to reach US$ 3511.9 million by the end of 2026, growing at a CAGR of 0.8% during 2021-2026.

This report focuses on Telmisartan volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Telmisartan market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Telmisartan market is segmented into

- Injection

- Freeze-Dried Powder

Segment by Application

- Hospital Use

- Clinic Use

- Others

Global Telmisartan Market: Regional Analysis

The Telmisartan market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Telmisartan market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Telmisartan Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Telmisartan market include:

- Pfizer

- Teva

- Boehringer Ingelheim

- Novartis

- Mylan

- Reddy's Laboratories (UK)

- Hema Pharmaceuticals Pvt

- Bayer

- GSK

- Astellas Pharma Inc

- Nippon Boehringer Ingelheim

- Abbott

- Takeda

- Beijing Wansheng Pharmaceutical

Global Telmisartan Market Research Report 2020

Table of Contents
1 Telmisartan Market Overview
1.1 Product Overview and Scope of Telmisartan
1.2 Telmisartan Segment by Type
1.2.1 Global Telmisartan Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Telmisartan Segment by Application
1.3.1 Telmisartan Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Others
1.4 Global Telmisartan Market Size Estimates and Forecasts
1.4.1 Global Telmisartan Revenue 2015-2026
1.4.2 Global Telmisartan Sales 2015-2026
1.4.3 Telmisartan Market Size by Region: 2020 Versus 2026
2 Global Telmisartan Market Competition by Manufacturers
2.1 Global Telmisartan Sales Market Share by Manufacturers (2015-2020)
2.2 Global Telmisartan Revenue Share by Manufacturers (2015-2020)
2.3 Global Telmisartan Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Telmisartan Manufacturing Sites, Area Served, Product Type
2.5 Telmisartan Market Competitive Situation and Trends
2.5.1 Telmisartan Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Telmisartan Players (Opinion Leaders)
3 Telmisartan Retrospective Market Scenario by Region
3.1 Global Telmisartan Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Telmisartan Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Telmisartan Market Facts & Figures by Country
3.3.1 North America Telmisartan Sales by Country
3.3.2 North America Telmisartan Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Telmisartan Market Facts & Figures by Country
3.4.1 Europe Telmisartan Sales by Country
3.4.2 Europe Telmisartan Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Telmisartan Market Facts & Figures by Region
3.5.1 Asia Pacific Telmisartan Sales by Region
3.5.2 Asia Pacific Telmisartan Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Telmisartan Market Facts & Figures by Country
3.6.1 Latin America Telmisartan Sales by Country
3.6.2 Latin America Telmisartan Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Telmisartan Market Facts & Figures by Country
3.7.1 Middle East and Africa Telmisartan Sales by Country
3.7.2 Middle East and Africa Telmisartan Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Telmisartan Historic Market Analysis by Type
4.1 Global Telmisartan Sales Market Share by Type (2015-2020)
4.2 Global Telmisartan Revenue Market Share by Type (2015-2020)
4.3 Global Telmisartan Price Market Share by Type (2015-2020)
4.4 Global Telmisartan Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Telmisartan Historic Market Analysis by Application
5.1 Global Telmisartan Sales Market Share by Application (2015-2020)
5.2 Global Telmisartan Revenue Market Share by Application (2015-2020)
5.3 Global Telmisartan Price by Application (2015-2020)
6 Company Profiles and Key Figures in Telmisartan Business
6.1 Pfizer
6.1.1 Corporation Information
6.1.2 Pfizer Description, Business Overview and Total Revenue
6.1.3 Pfizer Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Pfizer Products Offered
6.1.5 Pfizer Recent Development
6.2 Teva
6.2.1 Teva Telmisartan Production Sites and Area Served
6.2.2 Teva Description, Business Overview and Total Revenue
6.2.3 Teva Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Teva Products Offered
6.2.5 Teva Recent Development
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Telmisartan Production Sites and Area Served
6.3.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
6.3.3 Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Boehringer Ingelheim Products Offered
6.3.5 Boehringer Ingelheim Recent Development
6.4 Novartis
6.4.1 Novartis Telmisartan Production Sites and Area Served
6.4.2 Novartis Description, Business Overview and Total Revenue
6.4.3 Novartis Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novartis Products Offered
6.4.5 Novartis Recent Development
6.5 Mylan
6.5.1 Mylan Telmisartan Production Sites and Area Served
6.5.2 Mylan Description, Business Overview and Total Revenue
6.5.3 Mylan Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Mylan Products Offered
6.5.5 Mylan Recent Development
6.6 Reddy's Laboratories (UK)
6.6.1 Reddy's Laboratories (UK) Telmisartan Production Sites and Area Served
6.6.2 Reddy's Laboratories (UK) Description, Business Overview and Total Revenue
6.6.3 Reddy's Laboratories (UK) Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Reddy's Laboratories (UK) Products Offered
6.6.5 Reddy's Laboratories (UK) Recent Development
6.7 Hema Pharmaceuticals Pvt
6.6.1 Hema Pharmaceuticals Pvt Telmisartan Production Sites and Area Served
6.6.2 Hema Pharmaceuticals Pvt Description, Business Overview and Total Revenue
6.6.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Hema Pharmaceuticals Pvt Products Offered
6.7.5 Hema Pharmaceuticals Pvt Recent Development
6.8 Bayer
6.8.1 Bayer Telmisartan Production Sites and Area Served
6.8.2 Bayer Description, Business Overview and Total Revenue
6.8.3 Bayer Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Bayer Products Offered
6.8.5 Bayer Recent Development
6.9 GSK
6.9.1 GSK Telmisartan Production Sites and Area Served
6.9.2 GSK Description, Business Overview and Total Revenue
6.9.3 GSK Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.9.4 GSK Products Offered
6.9.5 GSK Recent Development
6.10 Astellas Pharma Inc
6.10.1 Astellas Pharma Inc Telmisartan Production Sites and Area Served
6.10.2 Astellas Pharma Inc Description, Business Overview and Total Revenue
6.10.3 Astellas Pharma Inc Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Astellas Pharma Inc Products Offered
6.10.5 Astellas Pharma Inc Recent Development
6.11 Nippon Boehringer Ingelheim
6.11.1 Nippon Boehringer Ingelheim Telmisartan Production Sites and Area Served
6.11.2 Nippon Boehringer Ingelheim Telmisartan Description, Business Overview and Total Revenue
6.11.3 Nippon Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Nippon Boehringer Ingelheim Products Offered
6.11.5 Nippon Boehringer Ingelheim Recent Development
6.12 Abbott
6.12.1 Abbott Telmisartan Production Sites and Area Served
6.12.2 Abbott Telmisartan Description, Business Overview and Total Revenue
6.12.3 Abbott Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Abbott Products Offered
6.12.5 Abbott Recent Development
6.13 Takeda
6.13.1 Takeda Telmisartan Production Sites and Area Served
6.13.2 Takeda Telmisartan Description, Business Overview and Total Revenue
6.13.3 Takeda Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Takeda Products Offered
6.13.5 Takeda Recent Development
6.14 Beijing Wansheng Pharmaceutical
6.14.1 Beijing Wansheng Pharmaceutical Telmisartan Production Sites and Area Served
6.14.2 Beijing Wansheng Pharmaceutical Telmisartan Description, Business Overview and Total Revenue
6.14.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Beijing Wansheng Pharmaceutical Products Offered
6.14.5 Beijing Wansheng Pharmaceutical Recent Development
7 Telmisartan Manufacturing Cost Analysis
7.1 Telmisartan Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Telmisartan
7.4 Telmisartan Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Telmisartan Distributors List
8.3 Telmisartan Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Telmisartan Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Telmisartan by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Telmisartan by Type (2021-2026)
10.2 Telmisartan Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Telmisartan by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Telmisartan by Application (2021-2026)
10.3 Telmisartan Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Telmisartan by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Telmisartan by Region (2021-2026)
10.4 North America Telmisartan Estimates and Projections (2021-2026)
10.5 Europe Telmisartan Estimates and Projections (2021-2026)
10.6 Asia Pacific Telmisartan Estimates and Projections (2021-2026)
10.7 Latin America Telmisartan Estimates and Projections (2021-2026)
10.8 Middle East and Africa Telmisartan Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Telmisartan Sales (MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Telmisartan Sales (MT) Comparison by Application: 2020 VS 2026
Table 3. Global Telmisartan Market Size by Type (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Telmisartan Manufacturers Covered in This Study
Table 5. Global Telmisartan Sales (MT) by Manufacturers (2015-2020)
Table 6. Global Telmisartan Sales Share by Manufacturers (2015-2020)
Table 7. Global Telmisartan Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Telmisartan Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Telmisartan Average Price (USD/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Telmisartan Sales Sites and Area Served
Table 11. Manufacturers Telmisartan Product Types
Table 12. Global Telmisartan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Telmisartan by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Telmisartan as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Telmisartan Players
Table 16. Global Telmisartan Sales (MT) by Region (2015-2020)
Table 17. Global Telmisartan Sales Market Share by Region (2015-2020)
Table 18. Global Telmisartan Revenue (Million US$) by Region (2015-2020)
Table 19. Global Telmisartan Revenue Market Share by Region (2015-2020)
Table 20. North America Telmisartan Sales by Country (2015-2020) (MT)
Table 21. North America Telmisartan Sales Market Share by Country (2015-2020)
Table 22. North America Telmisartan Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Telmisartan Revenue Market Share by Country (2015-2020)
Table 24. Europe Telmisartan Sales by Country (2015-2020) (MT)
Table 25. Europe Telmisartan Sales Market Share by Country (2015-2020)
Table 26. Europe Telmisartan Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Telmisartan Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Telmisartan Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific Telmisartan Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Telmisartan Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Telmisartan Revenue Market Share by Region (2015-2020)
Table 32. Latin America Telmisartan Sales by Country (2015-2020) (MT)
Table 33. Latin America Telmisartan Sales Market Share by Country (2015-2020)
Table 34. Latin America Telmisartan Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Telmisartan Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Telmisartan Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa Telmisartan Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Telmisartan Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Telmisartan Revenue Market Share by Country (2015-2020)
Table 40. Global Telmisartan Sales (MT) by Type (2015-2020)
Table 41. Global Telmisartan Sales Share by Type (2015-2020)
Table 42. Global Telmisartan Revenue (Million US$) by Type (2015-2020)
Table 43. Global Telmisartan Revenue Share by Type (2015-2020)
Table 44. Global Telmisartan Price (USD/Kg) by Type (2015-2020)
Table 45. Global Telmisartan Sales (MT) by Application (2015-2020)
Table 46. Global Telmisartan Sales Market Share by Application (2015-2020)
Table 47. Global Telmisartan Sales Growth Rate by Application (2015-2020)
Table 48. Pfizer Telmisartan Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 51. Pfizer Main Product
Table 52. Pfizer Recent Development
Table 53. Teva Telmisartan Corporation Information
Table 54. Teva Corporation Information
Table 55. Teva Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 56. Teva Main Product
Table 57. Teva Recent Development
Table 58. Boehringer Ingelheim Telmisartan Corporation Information
Table 59. Boehringer Ingelheim Corporation Information
Table 60. Boehringer Ingelheim Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 61. Boehringer Ingelheim Main Product
Table 62. Boehringer Ingelheim Recent Development
Table 63. Novartis Telmisartan Corporation Information
Table 64. Novartis Corporation Information
Table 65. Novartis Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 66. Novartis Main Product
Table 67. Novartis Recent Development
Table 68. Mylan Telmisartan Corporation Information
Table 69. Mylan Corporation Information
Table 70. Mylan Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 71. Mylan Main Product
Table 72. Mylan Recent Development
Table 73. Reddy's Laboratories (UK) Telmisartan Corporation Information
Table 74. Reddy's Laboratories (UK) Corporation Information
Table 75. Reddy's Laboratories (UK) Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 76. Reddy's Laboratories (UK) Main Product
Table 77. Reddy's Laboratories (UK) Recent Development
Table 78. Hema Pharmaceuticals Pvt Telmisartan Corporation Information
Table 79. Hema Pharmaceuticals Pvt Corporation Information
Table 80. Hema Pharmaceuticals Pvt Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 81. Hema Pharmaceuticals Pvt Main Product
Table 82. Hema Pharmaceuticals Pvt Recent Development
Table 83. Bayer Telmisartan Corporation Information
Table 84. Bayer Corporation Information
Table 85. Bayer Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 86. Bayer Main Product
Table 87. Bayer Recent Development
Table 88. GSK Telmisartan Corporation Information
Table 89. GSK Corporation Information
Table 90. GSK Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 91. GSK Main Product
Table 92. GSK Recent Development
Table 93. Astellas Pharma Inc Telmisartan Corporation Information
Table 94. Astellas Pharma Inc Corporation Information
Table 95. Astellas Pharma Inc Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 96. Astellas Pharma Inc Main Product
Table 97. Astellas Pharma Inc Recent Development
Table 98. Nippon Boehringer Ingelheim Telmisartan Corporation Information
Table 99. Nippon Boehringer Ingelheim Corporation Information
Table 100. Nippon Boehringer Ingelheim Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 101. Nippon Boehringer Ingelheim Main Product
Table 102. Nippon Boehringer Ingelheim Recent Development
Table 103. Abbott Telmisartan Corporation Information
Table 104. Abbott Corporation Information
Table 105. Abbott Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 106. Abbott Main Product
Table 107. Abbott Recent Development
Table 108. Takeda Telmisartan Corporation Information
Table 109. Takeda Corporation Information
Table 110. Takeda Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 111. Takeda Main Product
Table 112. Takeda Recent Development
Table 113. Beijing Wansheng Pharmaceutical Telmisartan Corporation Information
Table 114. Beijing Wansheng Pharmaceutical Corporation Information
Table 115. Beijing Wansheng Pharmaceutical Telmisartan Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 116. Beijing Wansheng Pharmaceutical Main Product
Table 117. Beijing Wansheng Pharmaceutical Recent Development
Table 118. Sales Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Telmisartan Distributors List
Table 121. Telmisartan Customers List
Table 122. Market Key Trends
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Global Telmisartan Sales (MT) Forecast by Type (2021-2026)
Table 126. Global Telmisartan Sales Market Share Forecast by Type (2021-2026)
Table 127. Global Telmisartan Revenue (Million US$) Forecast by Type (2021-2026)
Table 128. Global Telmisartan Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 129. Global Telmisartan Sales (MT) Forecast by Application (2021-2026)
Table 130. Global Telmisartan Revenue (Million US$) Forecast by Application (2021-2026)
Table 131. Global Telmisartan Sales (MT) Forecast by Region (2021-2026)
Table 132. Global Telmisartan Sales Market Share Forecast by Region (2021-2026)
Table 133. Global Telmisartan Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Global Telmisartan Revenue Market Share Forecast by Region (2021-2026)
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Telmisartan
Figure 2. Global Telmisartan Sales Market Share by Type: 2020 VS 2026
Figure 3. Injection Product Picture
Figure 4. Freeze-Dried Powder Product Picture
Figure 5. Global Telmisartan Consumption Market Share by Application: 2020 VS 2026
Figure 6. Hospital Use
Figure 7. Clinic Use
Figure 8. Others
Figure 9. Global Telmisartan Market Size 2015-2026 (US$ Million)
Figure 10. Global Telmisartan Sales Capacity (MT) (2015-2026)
Figure 11. Global Telmisartan Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Telmisartan Sales Share by Manufacturers in 2020
Figure 13. Global Telmisartan Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Telmisartan Revenue in 2019
Figure 15. Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Telmisartan Sales Market Share by Region (2015-2020)
Figure 17. Global Telmisartan Sales Market Share by Region in 2019
Figure 18. Global Telmisartan Revenue Market Share by Region (2015-2020)
Figure 19. Global Telmisartan Revenue Market Share by Region in 2019
Figure 20. North America Telmisartan Sales Market Share by Country in 2019
Figure 21. North America Telmisartan Revenue Market Share by Country in 2019
Figure 22. U.S. Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 23. U.S. Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 25. Canada Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Telmisartan Sales Market Share by Country in 2019
Figure 27. Europe Telmisartan Revenue Market Share by Country in 2019
Figure 28. Germany Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 29. Germany Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 31. France Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 33. U.K. Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 35. Italy Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 37. Russia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Telmisartan Sales Market Share by Region in 2019
Figure 39. Asia Pacific Telmisartan Revenue Market Share by Region in 2019
Figure 40. China Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 41. China Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 43. Japan Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 45. South Korea Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 47. India Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 49. Australia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 51. Taiwan Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 53. Indonesia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 55. Thailand Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 57. Malaysia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 59. Philippines Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 61. Vietnam Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Telmisartan Sales Market Share by Country in 2019
Figure 63. Latin America Telmisartan Revenue Market Share by Country in 2019
Figure 64. Mexico Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 65. Mexico Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 67. Brazil Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 69. Argentina Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Telmisartan Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Telmisartan Revenue Market Share by Country in 2019
Figure 72. Turkey Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 73. Turkey Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 75. Saudi Arabia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 77. U.A.E Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Telmisartan by Type (2015-2020)
Figure 79. Sales Market Share of Telmisartan by Type in 2019
Figure 80. Revenue Share of Telmisartan by Type (2015-2020)
Figure 81. Revenue Market Share of Telmisartan by Type in 2019
Figure 82. Global Telmisartan Sales Growth by Type (2015-2020) (MT)
Figure 83. Global Telmisartan Sales Market Share by Application (2015-2020)
Figure 84. Global Telmisartan Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Telmisartan by Application (2015-2020)
Figure 86. Global Revenue Share of Telmisartan by Application in 2020
Figure 87. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Reddy's Laboratories (UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Hema Pharmaceuticals Pvt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Astellas Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Nippon Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Beijing Wansheng Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Price Trend of Key Raw Materials
Figure 102. Manufacturing Cost Structure of Telmisartan
Figure 103. Manufacturing Process Analysis of Telmisartan
Figure 104. Telmisartan Industrial Chain Analysis
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Porter's Five Forces Analysis
Figure 108. North America Telmisartan Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 109. North America Telmisartan Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Telmisartan Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 111. Europe Telmisartan Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Telmisartan Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 113. Latin America Telmisartan Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Telmisartan Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 115. Middle East and Africa Telmisartan Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Telmisartan Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 117. Asia Pacific Telmisartan Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Bottom-up and Top-down Approaches for This Report
Figure 119. Data Triangulation
Figure 120. Key Executives Interviewed
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs